Cetuximab as second-line therapy in patients with metastatic esophageal adenocarcinoma: A phase II southwest oncology group study (S0415)

Philip J. Gold, Bryan Goldman, Syma Iqbal, Lawrence P. Leichman, Wu Zhang, Heinz Josef Lenz, Charles D. Blanke

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Fingerprint Dive into the research topics of 'Cetuximab as second-line therapy in patients with metastatic esophageal adenocarcinoma: A phase II southwest oncology group study (S0415)'. Together they form a unique fingerprint.

Medicine & Life Sciences